Your Comments On...

In Antipsychotics, Newer Isn't Better

Schizophrenia patients do as well, or perhaps even better, on older psychiatric drugs compared with newer and far costlier medications, according to a study published yesterday that overturns conventional wisdom about antipsychotic drugs, which cost the United States $10 billion a year.

By Shankar Vedantam

© 2006 The Washington Post Company